Emerging Technology Partners

Emerging Technology Partners (ETP) is a life sciences-focused venture capital firm founded in 2000, specializing in cross-border investments between the United States and China. The firm is dedicated to providing capital and strategic support to management teams aiming to build and commercialize breakthrough diagnostic and therapeutic products in the life sciences sector. ETP's mission is to deliver superior returns to investors by facilitating the growth of innovative companies in the biomedical industry.

ETP's investment strategy encompasses a broad spectrum, from seed stage to post-IPO rounds, positioning itself as a lead investor or a partner in syndicated rounds where key success elements are already established. The firm has a particular emphasis on biotechnology companies, leveraging its expertise to identify and support innovations that have the potential to transform healthcare. ETP's cross-border approach enables it to bridge the gap between the U.S. and Chinese markets, fostering strategic alliances and partnerships that accelerate growth and commercialization efforts.

With a team of investment partners located in San Francisco, Boston, Washington D.C., and Beijing, ETP is well-equipped to navigate the complexities of international markets. The firm's extensive experience and network allow it to provide comprehensive support to portfolio companies, including assistance in recruiting management teams, facilitating strategic alliances, and acquiring new products and technologies. ETP's commitment to innovation and excellence has established it as a prominent player in the venture capital landscape, dedicated to advancing the biomedical industry through strategic investments and partnerships.